Y. Drabu

449 total citations
22 papers, 261 citations indexed

About

Y. Drabu is a scholar working on Infectious Diseases, Molecular Medicine and Pharmacology. According to data from OpenAlex, Y. Drabu has authored 22 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Molecular Medicine and 7 papers in Pharmacology. Recurrent topics in Y. Drabu's work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Y. Drabu is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Y. Drabu collaborates with scholars based in United Kingdom and Belgium. Y. Drabu's co-authors include Shaheen Mehtar, Bradley J. Walsh, Jonathan A. Otter, Fiaz Ahmad, Michael Ruddy, F. Mayet, David M. Melville, Jane E. Ambler, Peter Wilmshurst and Ken Jarvis and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Transactions of the Royal Society of Tropical Medicine and Hygiene and Journal of Hospital Infection.

In The Last Decade

Y. Drabu

22 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Drabu United Kingdom 10 121 54 52 44 40 22 261
G Harvey United Kingdom 10 81 0.7× 23 0.4× 78 1.5× 84 1.9× 68 1.7× 16 297
Jana Kolman Slovenia 11 133 1.1× 63 1.2× 61 1.2× 24 0.5× 166 4.2× 14 290
Cosmina Zeana United States 9 151 1.2× 53 1.0× 96 1.8× 28 0.6× 114 2.9× 33 362
D T McLeod United Kingdom 9 75 0.6× 52 1.0× 52 1.0× 29 0.7× 202 5.0× 20 356
A. Seymour United Kingdom 11 70 0.6× 66 1.2× 98 1.9× 54 1.2× 192 4.8× 14 303
J. W. Harding United Kingdom 10 74 0.6× 131 2.4× 16 0.3× 34 0.8× 43 1.1× 22 400
Alex Studemeister United States 7 69 0.6× 44 0.8× 89 1.7× 46 1.0× 83 2.1× 16 229
Y. Berrouane France 8 188 1.6× 19 0.4× 47 0.9× 16 0.4× 138 3.5× 11 345
D. Lesage France 7 170 1.4× 24 0.4× 76 1.5× 45 1.0× 134 3.4× 33 307
Jolanta Miciulevičienė Lithuania 10 101 0.8× 44 0.8× 81 1.6× 27 0.6× 137 3.4× 16 327

Countries citing papers authored by Y. Drabu

Since Specialization
Citations

This map shows the geographic impact of Y. Drabu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Drabu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Drabu more than expected).

Fields of papers citing papers by Y. Drabu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Drabu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Drabu. The network helps show where Y. Drabu may publish in the future.

Co-authorship network of co-authors of Y. Drabu

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Drabu. A scholar is included among the top collaborators of Y. Drabu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Drabu. Y. Drabu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otter, Jonathan A., et al.. (2007). Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. Journal of Hospital Infection. 67(2). 182–188. 62 indexed citations
2.
Drabu, Y., et al.. (2004). Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoea. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(3). 215–217. 10 indexed citations
3.
Ambler, Jane E., et al.. (2001). In Vitro Activity of Gemifloxacin (SB-265805) Compared to Eleven Other Antimicrobial Agents Against Streptococcal Isolates, Excluding Streptococcus pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 20(4). 271–275. 5 indexed citations
4.
Ruddy, Michael, et al.. (2001). Hospital hairdresser as a potential source of cross-infection with MRSA. Journal of Hospital Infection. 49(3). 225–227. 20 indexed citations
6.
Ambler, Jane E., et al.. (1993). Mutator plasmid in a nalidixic acid-resistant strain of Shigella dysenteriae type 1. Journal of Antimicrobial Chemotherapy. 31(6). 831–839. 8 indexed citations
7.
Drabu, Y., et al.. (1991). The post-antibiotic effect of teicoplanin: monotherapy and combination studies. Journal of Antimicrobial Chemotherapy. 27(suppl B). 1–7. 5 indexed citations
8.
Drabu, Y., et al.. (1991). Refrigerated food storage in hospital ward areas. Journal of Hospital Infection. 18(1). 63–66. 1 indexed citations
9.
Mehtar, Shaheen, et al.. (1990). The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 25(6). 915–919. 15 indexed citations
10.
Reybrouck, Gerald, et al.. (1990). A multi-centre evaluation of two chlorhexidine-containing formulations for surgical hand disinfection. Journal of Hospital Infection. 16(2). 151–159. 12 indexed citations
11.
Drabu, Y., et al.. (1990). Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.. PubMed. 16(11). 557–63. 7 indexed citations
12.
Drabu, Y., et al.. (1989). Plasmid-mediated ceftazidime resistance. Journal of Antimicrobial Chemotherapy. 23(2). 287–290. 2 indexed citations
13.
Payne, David, et al.. (1989). Comparison of TEM-E3 and TEM-5 β-lactamases. Journal of Antimicrobial Chemotherapy. 24(4). 615–617. 4 indexed citations
14.
Drabu, Y., et al.. (1988). Teicoplanin in infections caused by methicillin-resistant staphylococci. Journal of Antimicrobial Chemotherapy. 21(suppl A). 89–92. 11 indexed citations
15.
Mehtar, Shaheen, et al.. (1986). Cross infection with Streptococcus pneumoniae through a resuscitaire.. BMJ. 292(6512). 25–26. 17 indexed citations
16.
Mehtar, Shaheen, et al.. (1986). Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 5(2). 248–251. 8 indexed citations
17.
Mehtar, Shaheen, et al.. (1986). Ciprofloxacin in the Treatment of Infections Caused by Gentamicin-Resistant Gram-Negative Bacteria. PubMed. 5(2). 119–122. 16 indexed citations
18.
Bettelheim, K. A., Y. Drabu, S. O’Farrell, et al.. (1983). Relationship of an epidemic strain of Escherichia coli O125.H21 to other serotypes of E. coli during an outbreak situation in a neonatal ward.. PubMed. 253(4). 509–14. 9 indexed citations
19.
Wilmshurst, Peter, et al.. (1979). Renal carcinoma with thrombocytopenia, clubbing, and hypertrophic osteoarthropathy.. BMJ. 1(6160). 381.1–381. 10 indexed citations
20.
Sanderson, P J & Y. Drabu. (1979). Antibiotic interaction against Staphylococcus aureus; use of a new technique. Journal of Antimicrobial Chemotherapy. 5(6). 728–730. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026